Wockhardt Members Approve Capital Raising Plans via QIP
Shital Jibhe / 09 Jun 2017
Wockhardt Ltd is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, France, UK, Ireland, and the US, and subsidiaries in the US, UK, Ireland and France.
Wockhardt Ltd is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, France, UK, Ireland, and the US, and subsidiaries in the US, UK, Ireland and France.
On Friday, in its BSE filing, the company announced that the members of the company have approved the capital raising plans of Rs 1000 crore through Qualified Institutional Placement (QIP).
Wockhardt hit a high of Rs 644 per share with gains as much as 1.4% in early hours of trade on Friday on the NSE. delivering negative returns of 32% in a period of one year, it has also underperformed the BSE
The stock had its 52-week high of Rs 1129 per share on July 21,
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.